Vaccination with Dendritic Cells Inhibits the Growth of Hepatic Metastases in B6 Mice
Authors:
- Zeinab Abdel-WahabZAZeinab Abdel-Wahab
- Carol VervaertCVCarol Vervaert
- Hilliard F. SeiglerHSHilliard F. Seigler
- 1 April 1998
- journal article
- Published by Elsevier in Cellular Immunology
- Vol. 185 (1) , 65-74
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- FLT3 Ligand Induces the Generation of Functionally Active Dendritic Cells in MiceCellular Immunology, 1997
- Dendritic cells: a major story unfoldsImmunology Today, 1995
- Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy?Immunology Today, 1995
- Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor AntigensScience, 1994
- Identification of a Peptide Recognized by Five Melanoma-Specific Human Cytotoxic T Cell LinesScience, 1994
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.Journal of Experimental Medicine, 1994
- Mechanisms of mouse spleen dendritic cell function in the generation of influenza-specific, cytolytic T lymphocytes.Journal of Experimental Medicine, 1992
- The Dendritic Cell System and its Role in ImmunogenicityAnnual Review of Immunology, 1991
- Human Epidermal Langerhans Cells Undergo Profound Morphologic and Phenotypical Changes During In Vitro CultureJournal of Investigative Dermatology, 1990
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988